The roles of chemokine receptor V (CCR5) and its polymorphism, rs333 in multiple sclerosis (MS) are controversial. We investigated the receptor and its deletion in a large MS (428) and a numerous control (831) population in Csongrád County (Hungary) and North-Bácska (Serbia). Taqman probes firstly were used for the allele discrimination. There was no significant difference in genotype (OR. =. 1.092, 95% CI. =. 0.807-1.478, p=. 0.568 for wt/wt (wt. =. wild type allele) vs wt/δ32, δ32/δ32 (δ32. =. δ32 base pair deletion allele)) or allele frequency (OR. =. 0.914, 95% CI. =. 0.692-1.207, p=. 0.525). Neither the deletion nor the wt allele affected the Expanded Disability Status Scale score or the age at onset. Our results indicate no association between the CCR5 δ32 allele and MS.
ASJC Scopus subject areas
- Immunology and Allergy